Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the
“Company”) today provided unaudited financial results for the three
months and year ended March 31, 2013.
... read more
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) and Sun
Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN,
NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries, “Sun
... read more
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the
“Company”) today provided unaudited financial results for the three and
nine month periods ended December 31, 2012.
... read more